PTGX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

PTGXProtagonist Therapeutics, Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

PTGXProtagonist Therapeutics, Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PTGX 2

JNJJanssen Biotech, Inc., a Johnson & Johnson company ("JNJ")customer

TAKTakeda Pharmaceuticals, Inc. ("Takeda")customer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customerSource: SEC EDGAR

25 more · LLY chain ›

PTGXProtagonist Therapeutics, Inc

145.73▲+0.61%· post 140.94

Mkt cap$9.4BRevenue$213MQ2 FY26Revenue$46MFY25

LLYELI Lilly & Co

1,418.01▲+0.03%· post 1,418.01

After hoursNov 2 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 2 '26

PTGXProtagonist Therapeutics, Inc

LLYELI Lilly & Co

145.73▲+0.61%post 140.94

Price

1,418.01▲+0.03%post 1,418.01

$9.4B

Mkt cap

$1.3T

Q2 FY26$213M

Revenue

$24.4BQ3 FY26

FY25$46M

Revenue

$65.2BFY25

PTGX145.73▲+0.61%vsLLY1,418.01▲+0.03%After hoursNov 2 '26